Is Ocular Therapeutix, Inc. overvalued?

Ocular Therapeutix, Inc. (OCUL) — key valuation metrics and fundamentals.

No verdict

Price

$6.21

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.37B

Dividend yield

0.0%

Return on equity

-59.5%

Sector

Healthcare

Fair value compares OCUL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks